4021.SR logo
SAU · 4021.SRMedical - Care FacilitiesUpdated Oct 24, 2026

Canadian General Medical Center Complex Company P/E ratio

Current valuation, historical context, and peer comparisons.

Current P/E ratio

36.91×

6.2% belowthe 5-observation annual average

Share price4.2
÷
Earnings per share0.1138

Price and EPS in quote currency. Calculation details

Investors are paying 36.91 for every 1 of reported earnings per share.

P/E over time

2021 – 2025
Annual P/ESelected-period average 39.33×
3-year average42.36×3 positive annual observations
5-year average39.33×5 positive annual observations
10-year average39.33×5 positive annual observations
Peer median · TTM15.44×7 peers with positive P/E

Historical P/E ratios

Annual period-end data · 5 observations

4021.SR annual P/E history, newest first
Period endP/EChange
Dec 31, 202543.64×-19.5%
Dec 31, 202454.23×+85.7%
Dec 31, 202329.20×+35.8%
Dec 31, 202221.50×-55.3%
Dec 31, 202148.06×N/M

Change is relative to the preceding observation. N/M values are excluded from averages.

How 4021.SR compares

Company P/E vs. peer trailing-12-month ratios

P/E comparison with 4021.SR and provider-selected peers
CompanyP/E ratio
4021.SR logo
4021.SR This stockCanadian General Medical Center Complex Company
36.91×
9546.SR logo
9546.SRNaba Alsaha Medical Services Company
15.44×
9527.SR logo
9527.SRAlf Meem Yaa for Medical Supplies and Equipment Company
14.38×
9627.SR logo
9627.SRTwareat Medical Care Co.
N/M
9530.SR logo
9530.SRArabian International Healthcare Holding Company
11.49×
9600.SR logo
9600.SRQomel Company Limited
29.51×
9594.SR logo
9594.SRAl-Modawat Specialized Medical Co.
4.53×
9587.SR logo
9587.SRLana Medical Co.
23.91×
9544.SR logo
9544.SRFuture Care Trading Co.
30.49×

Peers are selected by the data provider. Business models and earnings definitions can differ.

Put the numbers in context

What does 4021.SR’s P/E tell you?

01

Start with its own history

At 36.91×, 4021.SR is 6.2% below its 5-observation annual average. A lower multiple can reflect a lower price, higher earnings, or weaker growth expectations—not necessarily a bargain.

02

Compare like with like

The median of the 7 positive peer ratios above is 15.44×. Check growth, margins, debt, and earnings quality before interpreting the gap. A faster-growing business may justify a higher multiple.

03

Check what drives earnings

One-off gains can temporarily lower P/E; unusual charges can raise it. Reported earnings and forward estimates answer different questions. Pair this view with return on equity and liquidity for a fuller picture.

Keep your research connected

Take 4021.SR into your spreadsheet

Pull historical P/E into Excel or Google Sheets with Wisesheets. Build your own comparisons alongside the rest of your financial model.

Explore Wisesheets
Quarterly P/E · latest quarter
=WISE("4021.SR", "PE Ratio", "LQ")
LQ selects the latest reported quarter. Requires the Wisesheets add-in. See available data

Sources & calculation methodology

Current P/E

Share price 4.2 ÷ EPS 0.1138 = 36.91×. Data is supplied by Financial Modeling Prep through Wisesheets. Quote feed updated Oct 24, 2026; this is not a real-time trading quote.

History & averages

Annual and quarterly P/E observations are provided separately from the current quote. Averages use the latest 3, 5, or 10 annual observations, excluding missing and nonpositive ratios. Pre-IPO observations are omitted. These are period-end observations, not daily averages.

Data definitions and limitations

The current quote feed does not specify the exact EPS filing-period end or whether EPS is basic or diluted. We do not label it as forward P/E. Peer ratios are explicitly trailing-12-month (TTM) values. Historical observations do not include independently verified price and EPS inputs. Sources may update on different schedules; rounded inputs can produce small calculation differences. Historical comparisons describe past pricing, not an estimate of fair value.

4021.SR P/E ratio: common questions

The essentials behind the numbers.

Canadian General Medical Center Complex Company's current P/E is 36.91× based on the quote data last updated Oct 24, 2026. It represents the share price divided by reported earnings per share. Prices and earnings may refresh on different schedules.

Annual P/E uses earnings for a completed fiscal year. Trailing-12-month (TTM) P/E uses the latest four quarters, while forward P/E uses forecast earnings. These are not interchangeable. This page labels peer ratios as TTM and shows dated annual or quarterly historical observations; it does not show forward estimates.

N/M means not meaningful: the feed has no positive P/E for that observation. Negative or zero earnings should not be ranked as a low positive valuation multiple. N/M observations are excluded from the averages shown above.

Divide the share price by earnings per share (EPS). For example, a share price of 100 and EPS of 5 gives a P/E of 20×. This page uses the price and EPS supplied together in the quote when both are positive.

Price timestamps, EPS definitions, share classes, adjustments, and fiscal periods can differ. A forward P/E also uses forecast earnings rather than reported earnings. Compare the inputs and as-of dates before comparing two displayed ratios.

Not necessarily. The average describes previous market pricing, not fair value. Changes in earnings quality, growth expectations, debt, accounting, and business risk can justify a different multiple today.